Perfluorocyclopentene (PFCPE) is a cyclic perfluorinated compound with the molecular formula C5F8. It is a colorless, odorless, and non-flammable gas at room temperature. PFCPE is a highly stable and inert compound due to the presence of strong C-F bonds. It has been studied for its potential applications in various fields, including as a dielectric fluid, a refrigerant, and a component in high-performance polymers. The synthesis of PFCPE typically involves the fluorination of cyclopentene or cyclopentane using elemental fluorine or a fluorinating agent. The effects of PFCPE on human health are not well-studied, but its inert nature suggests low toxicity. Research on PFCPE is driven by its potential applications in various industries. Its stability and inertness make it a promising candidate for use in demanding environments. For example, its high dielectric strength makes it suitable for use as a dielectric fluid in electrical equipment. PFCPE is also being investigated as a refrigerant due to its low global warming potential (GWP). Furthermore, its ability to withstand high temperatures and pressures makes it a valuable component in high-performance polymers.'
perfluorocyclopentene: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 11212 |
| MeSH ID | M0511398 |
| Synonym |
|---|
| unii-zkg7dky9s2 |
| zkg7dky9s2 , |
| 4-05-00-00212 (beilstein handbook reference) |
| cyclopentene, 1,2,3,3,4,4,5,5-octafluoro- |
| octafluorocyclopentene |
| cyclopentene, octafluoro- |
| perfluorocyclopentene |
| brn 1879470 |
| einecs 209-203-0 |
| 559-40-0 |
| 1,2,3,3,4,4,5,5-octafluorocyclopentene |
| O0292 |
| A830866 |
| 1,2,3,3,4,4,5,5-octakis(fluoranyl)cyclopentene |
| AKOS015853339 |
| oxamicacidsodiumsalt |
| flon c 1418 |
| 1,2,3,3,4,4,5,5-octafluoro-1-cyclopentene # |
| cyclopentene, perfluoro |
| DTXSID7073193 |
| mfcd00013745 |
| AS-47653 |
| perfluorocyclopent-1-ene |
| 1,2,3,3,4,4,5,5-octafluoro-1-cyclopentene |
| F14940 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (23.34) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 2 (28.57%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (71.43%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||